Fundraising Fox

Simcha Therapeutics

Delaware LLC · 4 known investors

simchatx.com ↗

A drug discovery company advancing novel medicines targeting unexplored areas of immune biology, with a focus on cancer treatments.

Biotechin /simcha-therapeutics

Founders & leadership

YL
Yiming LiDirector
AH
Axel HoosDirector
TR
Terry RosenDirector
AR
Aaron RingExecutive Officer, Director
JB
Jake BauerExecutive Officer, Director
BM
Beatrice McQueenExecutive Officer
SR
Sanuj RavindranExecutive Officer, Director
RS
Richard SollManager
JC
Joseph CatinoExecutive Officer

Investors · 4

Connecticut InnovationsNew Haven · $500K – $2M
Pfizer Venture Investments$5M – $20M
Axial VCreportedSan Francisco · $100K – $5M
SR One Capital ManagementreportedRedwood City

Reported raises · per SEC filings

Form D private placements
▶$7.1MraisedJun 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yiming LiDirector
  • Axel HoosDirector
  • Terry RosenDirector
  • Aaron RingExecutive Officer, Director
  • Jake BauerExecutive Officer, Director
  • Beatrice McQueenExecutive Officer
  • Sanuj RavindranExecutive Officer, Director
Offering amount
$10M
Amount sold
$7.1M
First sale
Jun 2025
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedSep 2021 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Simeon GeorgeDirector
  • Terry L. RosenDirector
  • Aaron RingExecutive Officer, Director
  • Lennart H. LeeDirector
  • Beatrice McQueenExecutive Officer
Offering amount
$40M
Amount sold
$40M
First sale
Aug 2021
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.6MraisedMay 2020 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Aaron RingExecutive Officer, Director
  • Terry L. RosenDirector
  • Lennart H. LeeDirector
  • Gu CuipingDirector
  • Beatrice McQueenExecutive Officer
Offering amount
$25.6M
Amount sold
$16.6M
First sale
May 2020
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MraisedJul 2018 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard SollDirector
  • Terry RosenDirector
  • Aaron RingExecutive Officer, Director
  • Joseph CatinoExecutive Officer
Offering amount
$6M
Amount sold
$4.4M
First sale
Jul 2018
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news